ReviewEuropean geriatric medicine2026
Rethinking sarcopenia: a conceptual shift towards a muscle health continuum.
Review in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Advancing muscle health: from technical and clinical research to practice.Frontiers in rehabilitation sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCurrent guideline-based approaches to sarcopenia are operationalised around thresholds of muscle mass, strength, and performance, which limit the opportunities for early/preventive intervention. This view insufficiently reflects skeletal muscle as a multifunctional organ and fails to capture its dynamic and heterogeneous nature. The objective of this manuscript is to place sarcopenia within this muscle health continuum.
methodsExpert discussions were conducted to identify conceptual limitations in existing approaches and to explore opportunities for improvement. These discussions were complemented by a narrative review of the literature, forming an integrative conceptual framework.
resultsA six-stage muscle health continuum is proposed in which sarcopenia is positioned as an advanced, pathological state rather than a binary diagnosis. Conceptual definitions of muscle health and muscle failure are introduced, alongside causal factors as potential targets for treatment as well as an aetiological stratification into subtypes. The framework is aligned with the International Classification of Functioning, Disability and Health to contextualise muscle dysfunction in terms of functioning and disability. To enhance diagnostic resolution and treatment monitoring, the concept of muscle profile analysis is introduced, supporting the use of direct muscle visualisation techniques such as ultrasound, computed tomography, and magnetic resonance imaging.
conclusionPositioning sarcopenia within a broader muscle health continuum reframes it from a late-stage geriatric diagnosis into a condition embedded within a lifelong trajectory. This conceptual shift hopes to kindle discussions about earlier assessment, preventive strategies, and individualised interventions, laying the foundation for future research, clinical innovation, and guideline evolution aimed at improving patient outcomes.
Indexed as
Identifiers
42035397What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.